CN Patent

CN111018846A — 化合物晶型

Assigned to Hutchmed Ltd · Expires 2020-04-17 · 6y expired

What this patent protects

本发明涉及药学领域，提供了化合物6‑((6,7‑二甲氧基喹唑啉‑4‑基)氧基)‑N,2‑二甲基苯并呋喃‑3‑甲酰胺的新晶型、溶剂合物及其晶型、其药物组合物，及其制备方法和应用。

USPTO Abstract

本发明涉及药学领域，提供了化合物6‑((6,7‑二甲氧基喹唑啉‑4‑基)氧基)‑N,2‑二甲基苯并呋喃‑3‑甲酰胺的新晶型、溶剂合物及其晶型、其药物组合物，及其制备方法和应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN111018846A
Jurisdiction: CN
Classification: —
Expires: 2020-04-17
Drug substance claim: No
Drug product claim: No
Assignee: Hutchmed Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.